Washington University-Internal Medicine/Oncology ( Site 0124) — St Louis, Missouri

Washington University-Internal Medicine/Oncology ( Site 0124) is a clinical research site located in St Louis, Missouri, United States 63110.

Crixeo Clinical Trials Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Washington University-Internal Medicine/Oncology ( Site 0124) has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in St Louis

Browse all research sites in Missouri · View every site in St Louis

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Washington University-Internal Medicine/Oncology ( Site 0124)?

Washington University-Internal Medicine/Oncology ( Site 0124) has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Washington University-Internal Medicine/Oncology ( Site 0124) conducted?

Washington University-Internal Medicine/Oncology ( Site 0124) has 2 clinical trials on record, with 2 currently active. Their work covers Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease.

Is Washington University-Internal Medicine/Oncology ( Site 0124) accredited by Crixeo Clinical Trials?

Washington University-Internal Medicine/Oncology ( Site 0124) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Washington University-Internal Medicine/Oncology ( Site 0124)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.